Candidate-gene approaches (analysing molecules known to regulate pathways altered in cholesteatoma) have found increased expression of interleukin-1 (IL1), tumor necrosis factor-alpha (TNFα), and defects in the regulation of epidermal growth factor receptor (EGFR) [11]. Here, EGFR is linked to cholesteatoma.